Sean Dodge
Stock Analyst at BMO Capital
(2.03)
# 2,956
Out of 5,182 analysts
160
Total ratings
34.48%
Success rate
-4.49%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Upgrades: Outperform | $85 → $105 | $86.04 | +22.04% | 14 | Apr 9, 2026 | |
| PHR Phreesia | Maintains: Outperform | $32 → $14 | $9.17 | +52.67% | 17 | Mar 31, 2026 | |
| ICLR ICON Public Limited Company | Upgrades: Outperform | $100 → $130 | $119.68 | +8.62% | 4 | Mar 26, 2026 | |
| AVAH Aveanna Healthcare Holdings | Maintains: Outperform | $11 → $10 | $6.77 | +47.71% | 2 | Mar 20, 2026 | |
| OMDA Omada Health | Maintains: Outperform | $27 → $18 | $14.14 | +27.30% | 2 | Mar 6, 2026 | |
| TDOC Teladoc Health | Maintains: Market Perform | $8 → $5 | $5.69 | -12.13% | 18 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Outperform | $45 → $54 | $47.64 | +13.35% | 2 | Feb 26, 2026 | |
| WAY Waystar Holding | Maintains: Outperform | $47 → $30 | $25.80 | +16.28% | 4 | Feb 18, 2026 | |
| SHC Sotera Health Company | Reinstates: Outperform | $24 | $16.30 | +47.24% | 12 | Jan 9, 2026 | |
| BTSG BrightSpring Health Services | Initiates: Outperform | $40 | $47.27 | -15.38% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $120 | $94.32 | +27.23% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $2.84 | +146.48% | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $260 | $176.46 | +47.34% | 7 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $9 | $6.22 | +44.69% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $300 | $167.95 | +78.62% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $8 | $6.89 | +16.11% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $24.02 | +24.90% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $20 | $19.17 | +4.33% | 14 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $55 | $24.71 | +122.58% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $600 | $520.60 | +15.25% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $6 | $1.32 | +354.55% | 10 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $88 | $30.05 | +191.18% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $7 → $6 | $7.17 | -16.32% | 11 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $23.25 | -39.78% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $2.27 | +340.53% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $192.63 | -82.87% | 1 | Sep 14, 2022 |
HealthEquity
Apr 9, 2026
Upgrades: Outperform
Price Target: $85 → $105
Current: $86.04
Upside: +22.04%
Phreesia
Mar 31, 2026
Maintains: Outperform
Price Target: $32 → $14
Current: $9.17
Upside: +52.67%
ICON Public Limited Company
Mar 26, 2026
Upgrades: Outperform
Price Target: $100 → $130
Current: $119.68
Upside: +8.62%
Aveanna Healthcare Holdings
Mar 20, 2026
Maintains: Outperform
Price Target: $11 → $10
Current: $6.77
Upside: +47.71%
Omada Health
Mar 6, 2026
Maintains: Outperform
Price Target: $27 → $18
Current: $14.14
Upside: +27.30%
Teladoc Health
Feb 26, 2026
Maintains: Market Perform
Price Target: $8 → $5
Current: $5.69
Upside: -12.13%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $45 → $54
Current: $47.64
Upside: +13.35%
Waystar Holding
Feb 18, 2026
Maintains: Outperform
Price Target: $47 → $30
Current: $25.80
Upside: +16.28%
Sotera Health Company
Jan 9, 2026
Reinstates: Outperform
Price Target: $24
Current: $16.30
Upside: +47.24%
BrightSpring Health Services
Nov 13, 2025
Initiates: Outperform
Price Target: $40
Current: $47.27
Upside: -15.38%
Nov 13, 2025
Initiates: Market Perform
Price Target: $120
Current: $94.32
Upside: +27.23%
Nov 13, 2025
Initiates: Outperform
Price Target: $7
Current: $2.84
Upside: +146.48%
Nov 13, 2025
Initiates: Outperform
Price Target: $260
Current: $176.46
Upside: +47.34%
Nov 13, 2025
Initiates: Market Perform
Price Target: $9
Current: $6.22
Upside: +44.69%
Nov 13, 2025
Initiates: Market Perform
Price Target: $300
Current: $167.95
Upside: +78.62%
Nov 13, 2025
Initiates: Outperform
Price Target: $8
Current: $6.89
Upside: +16.11%
Nov 13, 2025
Initiates: Outperform
Price Target: $30
Current: $24.02
Upside: +24.90%
Nov 13, 2025
Initiates: Market Perform
Price Target: $20
Current: $19.17
Upside: +4.33%
Nov 13, 2025
Initiates: Market Perform
Price Target: $55
Current: $24.71
Upside: +122.58%
Nov 13, 2025
Initiates: Market Perform
Price Target: $600
Current: $520.60
Upside: +15.25%
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $1.32
Upside: +354.55%
Feb 26, 2025
Maintains: Outperform
Price Target: $75 → $88
Current: $30.05
Upside: +191.18%
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $7.17
Upside: -16.32%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $23.25
Upside: -39.78%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $2.27
Upside: +340.53%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $192.63
Upside: -82.87%